| abstract |
Disclosed are Calcitonin-Gene-Related Peptide antagonists (CGRP antagonists) of general formula (I), in which B, R1 and R2 are defined as defined in the specification, their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and salts, in addition to the hydrates of their salts, in particular their physiologically compatible salts, with inorganic or organic acids or bases. The disclosure also relates to medicaments containing said compounds, their use and a method for their production. |